PRKCZ and ovarian carcinoma: It has also been observed that PRKCZ is mislocalized in a subset of ovarian cancers, and it was suggested that this mislocalization may reflect a role for apical-basal loosening, thus disrupting cell-cell adhesion, as well as increasing cell growth [9]; however, additional evidence supporting the role of PRKCZ in ovarian cancer remains limited.